BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15154527)

  • 1. Comparison of prostate-specific antigen adjusted for transition zone volume versus prostate-specific antigen density in predicting prostate cancer by transrectal ultrasonography.
    Sung DJ; Cho SB; Kim YH; Oh YW; Lee NJ; Kim JH; Chung KB; Moon DG
    J Ultrasound Med; 2004 May; 23(5):615-22. PubMed ID: 15154527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer.
    Moon DG; Cheon J; Kim JJ; Yoon DK; Koh SK
    Int J Urol; 1999 Sep; 6(9):455-62. PubMed ID: 10510891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC
    J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer.
    Maeda H; Arai Y; Ishitoya S; Okubo K; Aoki Y; Okada T
    J Urol; 1997 Dec; 158(6):2193-6. PubMed ID: 9366342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.
    Zlotta AR; Djavan B; Marberger M; Schulman CC
    J Urol; 1997 Apr; 157(4):1315-21. PubMed ID: 9120930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
    Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
    Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
    Kang SH; Bae JH; Park HS; Yoon DK; Moon DG; Kim JJ; Cheon J
    Int J Urol; 2006 Jul; 13(7):910-4. PubMed ID: 16882054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
    Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
    Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
    Milonas D; Trumbeckas D
    Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.
    Okihara K; Fritsche HA; Ayala A; Johnston DA; Allard WJ; Babaian RJ
    J Urol; 2001 Jun; 165(6 Pt 1):1930-6. PubMed ID: 11371884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
    Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
    J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels.
    Horninger W; Reissigl A; Klocker H; Rogatsch H; Fink K; Strasser H; Bartsch G
    Prostate; 1998 Nov; 37(3):133-7; discussion 138-9. PubMed ID: 9792130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.
    Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
    Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer.
    Ferreira MD; Koff WJ
    Int Braz J Urol; 2005; 31(2):137-45; discussion 146. PubMed ID: 15877833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL.
    Ito K; Ohi M; Yamamoto T; Miyamoto S; Kurokawa K; Fukabori Y; Suzuki K; Yamanaka H
    Cancer; 2002 Nov; 95(10):2112-9. PubMed ID: 12412164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.